<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25444032</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>10</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-8511</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>24</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2015</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</Title>
<ISOAbbreviation>J Stroke Cerebrovasc Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Relation between cardiovascular disease risk markers and brain infarcts detected by magnetic resonance imaging in an elderly population.</ArticleTitle>
<Pagination>
<MedlinePgn>312-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jstrokecerebrovasdis.2014.08.027</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1052-3057(14)00431-5</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Established cardiovascular risk markers, such as hypertension, are associated with increased risk of brain infarcts. The newer markers N-terminal pro-brain natriuretic peptide, troponin I, C-reactive protein, and cystatin C may affect the risk of cardiovascular events and potentially, thereby, also stroke. We investigated the association between established and new risk markers for cardiovascular disease and brain infarcts detected by magnetic resonance imaging (MRI) at age 75.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Four hundred six randomly selected subjects from the Prospective Investigation of the Vasculature in Uppsala Seniors study were examined with MRI of the brain at age 75. Blood samples, measurements, and dedicated questionnaires at age 70 were used for analysis of risk markers. A history of diseases had been obtained at age 70 and 75. MRI was evaluated regarding lacunar and cortical infarcts. Univariate associations between outcomes and risk markers were assessed with logistic regression models.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">One or more infarcts were seen in 23% of the subjects (20% had only lacunar infarcts, 1% had only cortical infarcts, and 2% had both). Hypertension (odds ratio [OR] 2.6, 95% confidence interval [CI] 1.4, 4.7) and obesity (OR 1.3; CI 1.0, 1.8) were significantly associated with increased risk of brain infarction. The newer risk markers were not significantly associated with the brain infarcts.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The new markers were not associated with the predominantly lacunar infarcts in our 75-year-old population, why troponin I and NT-proBNP may be associated mainly with cardioembolic infarcts as shown recently.</AbstractText>
<CopyrightInformation>Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nylander</LastName>
<ForeName>Ruta</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden. Electronic address: ruta.nylander@radiol.uu.se.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lind</LastName>
<ForeName>Lars</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wikström</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lindahl</LastName>
<ForeName>Bertil</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Venge</LastName>
<ForeName>Per</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Larsson</LastName>
<ForeName>Anders</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ärnlöv</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden; School of Health and Social Studies, Dalarna University, Falun, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berglund</LastName>
<ForeName>Lars</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahlström</LastName>
<ForeName>Håkan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johansson</LastName>
<ForeName>Lars</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden; AstraZeneca, Gothenburg, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Larsson</LastName>
<ForeName>Elna-Marie</ForeName>
<Initials>EM</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Stroke Cerebrovasc Dis</MedlineTA>
<NlmUniqueID>9111633</NlmUniqueID>
<ISSNLinking>1052-3057</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biomarkers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020520">Brain Infarction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002318">Cardiovascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Magnetic resonance</Keyword>
<Keyword MajorTopicYN="N">hypertension</Keyword>
<Keyword MajorTopicYN="N">lacunar infarctions</Keyword>
<Keyword MajorTopicYN="N">risk factors</Keyword>
<Keyword MajorTopicYN="N">stroke</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>06</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2014</Year>
<Month>08</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>08</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25444032</ArticleId>
<ArticleId IdType="pii">S1052-3057(14)00431-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2014.08.027</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>